Authors:
HLA MM
DAVIS JW
ROSS PD
WASNICH RD
YATES AJ
RAVN P
HOSKING DJ
MCCLUNG MR
Citation: Mm. Hla et al., MULTICENTER STUDY OF THE INFLUENCE OF FAT AND LEAN MASS ON BONE-MINERAL CONTENT - EVIDENCE FOR DIFFERENCES IN THEIR RELATIVE INFLUENCE AT MAJOR FRACTURE SITES, The American journal of clinical nutrition, 64(3), 1996, pp. 354-360
Citation: S. Patel et al., QUANTITATIVE BONE-SCINTIGRAPHY IN THE MANAGEMENT OF MONOSTOTIC PAGETS-DISEASE OF BONE, Arthritis and rheumatism, 38(10), 1995, pp. 1506-1512
Citation: Md. Stone et al., USE OF THE BISPHOSPHONATE SPACE IN TREATMENT AND RETREATMENT OF PAGETS-DISEASE, Seminars in arthritis and rheumatism, 23(4), 1994, pp. 278-278
Citation: S. Patel et al., ASSESSMENT OF RESPONSE OF PAGETS-DISEASE TO PAMIDRONATE USING THE HALF-LIFE OF CHANGE IN ALKALINE-PHOSPHATASE, British journal of rheumatology, 32, 1993, pp. 42-42
Authors:
REASNER CA
STONE MD
HOSKING DJ
BALLAH A
MUNDY GR
Citation: Ca. Reasner et al., ACUTE CHANGES IN CALCIUM HOMEOSTASIS DURING TREATMENT OF PRIMARY HYPERPARATHYROIDISM WITH RISEDRONATE, The Journal of clinical endocrinology and metabolism, 77(4), 1993, pp. 1067-1071
Authors:
DEMULDER A
TAKAHASHI S
SINGER FR
HOSKING DJ
ROODMAN GD
Citation: A. Demulder et al., ABNORMALITIES IN OSTEOCLAST PRECURSORS AND MARROW ACCESSORY CELLS IN PAGETS-DISEASE, Endocrinology, 133(5), 1993, pp. 1978-1982
Citation: S. Patel et al., DRUGS USED IN THE TREATMENT OF METABOLIC BONE-DISEASE - CLINICAL-PHARMACOLOGY AND THERAPEUTIC USE, Drugs, 46(4), 1993, pp. 594-617